Weight Loss and Improvements in Markers of Metabolic Risk in Overweight and Obese Subjects Completing 56 Weeks of Treatment with Naltrexone SR/Bupropion SR

被引：0

|

作者：

Fujioka, Ken

Billes, Sonja K.

Burns, Colleen

Harris-Collazo, Raul

Kim, Dennis D.

Dunayevich, Eduardo

Greenway, Frank L.

机构：

来源：

DIABETES | 2011年 / 60卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1928-P

引用

收藏

页码：A520 / A521

页数：2

相关论文

共 50 条

[1] Reduced Depressive Symptoms and Weight Loss in Depressed Overweight/Obese Subjects Completing 24 Weeks of Open Label Therapy With Naltrexone SR/Bupropion SR
McElroy, Susan L.
Guerdjikova, Anna
Mignon, Laurence
Burns, Colleen
Kim, Dennis D.
Landbloom, Ronald
Dunayevich, Eduardo
OBESITY, 2010, 18 : S152 - S152
[2] Completion of 56 Weeks of Naltrexone SR/Bupropion SR Combination Therapy Increases Likelihood of Achieving Improvements in Markers of Cardiometabolic Risk Associated With Clinically Meaningful Weight Loss
Fujioka, Ken
Greenway, Frank L.
Rubino, Domenica
Clapper, Brenda
Burns, Colleen
Klassen, Preston
Harris-Collazo, Raul
OBESITY, 2011, 19 : S179 - S179
[3] Improved Glycemic Control and Weight Loss with Naltrexone SR/Bupropion SR Combination Therapy in Overweight/Obese Subjects with Type 2 Diabetes
Gupta, Alok K.
Hollander, Priscilla
Bays, Harold
Guttadauria, Maria
Erickson, Janelle
Kim, Dennis
Dunayevich, Eduardo
DIABETES, 2010, 59 : A687 - A687
[4] Naltrexone SR/Bupropion SR Combination Therapy Reduced Weight and Improved Weight-Related Quality of Life and Physical Health in Overweight and Obese Subjects
Kolotkin, Ronette L.
Still, Christopher
Maier, Holly
Burns, Colleen
Harris-Collazo, Raul
Dunayevich, Eduardo
Aronne, Louis J.
DIABETES, 2011, 60 : A506 - A507
[5] Naltrexone SR/Bupropion SR Combination Therapy Improves Control of Eating and Reduces Food Cravings in Overweight/Obese Subjects
Fujioka, Ken
Greenway, Frank L.
Billes, Sonja K.
Burns, Colleen
Harris-Collazo, Raul
Kim, Dennis D.
Dunayevich, Eduardo
OBESITY, 2010, 18 : S152 - S152
[6] Naltrexone SR/Bupropion SR Combination Therapy Improves Control of Eating and Reduces Food Cravings in Overweight and Obese Subjects
Hill, James O.
Wyatt, Holly
Billes, Sonja K.
Burns, Colleen
Harris-Collazo, Raul
Dunayevich, Eduardo
Blundell, John
DIABETES, 2011, 60 : A506 - A506
[7] Naltrexone SR/Bupropion SR-Induced Weight Loss is Independent of Nausea
Foreyt, John P.
Hill, James
Maier, Holly
Dunayevich, Eduardo
Kim, Dennis D.
OBESITY, 2009, 17 : S109 - S110
[8] Naltrexone SR/Bupropion SR Combination Therapy Reduced Body Weight and Improved Metabolic Risk Factors
Rock, Cheryl L.
Maier, Holly
Dunayevich, Eduardo
Kim, Dennis D.
Perri, Michael G.
OBESITY, 2009, 17 : S110 - S110
[9] An Open-Label Study Evaluating the Naltrexone SR/Bupropion SR Combination Therapy in Overweight or Obese Subjects with Major Depression
McElroy, Susan L.
Guerdjikova, Anna I.
Rosen, Amy
Kim, Dennis D.
Landbloom, Ronald
Dunayevich, Eduardo
DIABETES, 2010, 59 : A483 - A484
[10] Naltrexone SR/Bupropion SR Combination Therapy Reduces Total and Visceral Adiposity in Overweight and Obese Subjects in the COR-I Study
Smith, Steven R.
Church, Timothy
Geohas, Jeffrey
Griffin, Carl
Harper, Wayne L.
Krieger, Diane
Loper, Judy F.
Mudaliar, Sunder
Woodruff, Chivers
Guttadauria, Maria
Henry, Eugenia
Kim, Dennis D.
Dunayevich, Eduardo
DIABETES, 2010, 59 : A483 - A483

← 1 2 3 4 5 →